Travere Therapeutics, Inc. (TVTX) Technical Analysis & Indicators

Travere Therapeutics, Inc. (TVTX) — Price $50.84 (closing price, October 28, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Travere Therapeutics, Inc. (TVTX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral, once-daily, non-immunosuppressive medication targeting two pathways of disease progression (endothelin-1 and angiotensin-II).

Price Performance

1 month-15.19%
3 months-8.96%
Year-to-date+33.16%
1 year+69.71%
3 years+652.66%
5 years+76.61%
10 years+169.92%

52-Week Range

52-week High$68.73
52-week Low$22.59
Avg Volume (90d)1.7M

Technical Indicators

SMA 50$59.91
SMA 200$46.32
Beta0.87
30-day Volatility (annualised)39.7%
Price vs SMA 50-15.1%
Price vs SMA 200+9.8%

Monthly Close (12 months)

MonthCloseChange
2025-12$38.21
2026-01$31.09-18.6%
2026-02$29.79-4.2%
2026-03$29.71-0.3%
2026-04$42.12+41.8%
2026-05$47.18+12.0%
2026-06$56.81+20.4%
2026-07$55.89-1.6%
2026-07$55.89+0.0%
2026-08$66.28+18.6%
2026-09$58.88-11.2%
2026-10$50.88-13.6%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-11-02$-0.04$198M
2026-08-04$-0.13$157M
2026-05-04$-0.30$136M
2026-02-19$0.03$145M
2025-10-30$-0.31$147M
2025-08-06$-0.28$100M
2025-05-01$-0.55$89M

Price

Price$50.84 (closing price, October 28, 2026)
Market Cap$4.8B
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book197.35
EV / EBITDA916.44
Dividend Yield0.00%

Financial Health

Debt / Equity25.16
Current Ratio4.05
Piotroski F-Score7
Altman Z-Score1.78

Related companies: VRTX · 0QZU.L · 0R2M.L · MRNA · REGN · ARGX · 0QNO.L · RVMD

Explore sector: Healthcare · Biotechnology

More sections of TVTX: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks